Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsThe HCPFive: Top News for Healthcare Providers from the Week of 10/25
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.
Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.
Here's some of what is coming soon to NeurologyLive® this week.
Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
1.
Global inequalities found in cancer research funding
2.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
3.
Beyond What Is Visible in Myelofibrosis?
4.
Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis
5.
FDA Approves Hemophilia B Second Gene Therapy.
1.
Oncology in High-Risk Populations: Prevention, Screening and Early Detection in Hereditary and Sex-Specific Cancers
2.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
3.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
4.
AI Detection of Abnormal Platelet Morphology: Clinical Applications and Scientific Advances
5.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Understanding Anemia: Causes and Treatment
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
4.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge